Literature DB >> 2997980

Human T-cell leukemia virus type II: primary structure analysis of the major internal protein, p24 and the nucleic acid binding protein, p15.

S G Devare, Y Kim, J L Fox, J Getchell, C Cabradilla, V S Kalyanaraman.   

Abstract

The 24,000-molecular-weight major internal protein (p24) and the 15,000-molecular-weight nucleic acid binding protein (p15) of human T-cell leukemia virus type II (HTLV-II) were subjected to amino acid composition and amino-terminal amino acid sequence analysis. A comparison of amino acid composition of p24 and p15 of HTLV-II with those of the analogous proteins of HTLV-I revealed that these two proteins share overall similarity. Further, alignment of the amino-terminal amino acid sequence for the first 27 residues of p24 and 34 residues of p15 from HTLV-II showed extensive sequence homology with analogous proteins of HTLV-I. These data suggest that although disease associated with HTLV-I is malignant T-cell leukemia and that associated with HTLV-II is a relatively benign variant of hairy-cell leukemia, HTLV-I and HTLV-II are closely related to each other, at least in their gag-gene-encoded sequences.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2997980     DOI: 10.1016/0042-6822(85)90434-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  3 in total

1.  Bacterial expression of the acquired immunodeficiency syndrome retrovirus p24 gag protein and its use as a diagnostic reagent.

Authors:  D J Dowbenko; J R Bell; C V Benton; J E Groopman; H Nguyen; D Vetterlein; D J Capon; L A Lasky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

2.  Human T-cell lymphotropic virus type III: immunologic characterization and primary structure analysis of the major internal protein, p24.

Authors:  J M Casey; Y Kim; P R Andersen; K F Watson; J L Fox; S G Devare
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users.

Authors:  Karin Hedenmalm; Alexandra Pacurariu; Jim Slattery; Xavier Kurz; Gianmario Candore; Rob Flynn
Journal:  Drug Saf       Date:  2021-07-17       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.